Tofacitinib Impurity and its Related Products
Displaying 58 results of Tofacitinib Impurity
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| (3R,4S)-Tofacitinib citirate | Impurity | CS-O-39729 | 2174011-53-9 | Enquire |
| (3R,4S)-Tofacitinib | Impurity | CS-T-62103 | 1092578-46-5 | In Stock |
| (3S,4R)-Tofacitinib | Impurity | CS-T-62105 | 1092578-48-7 | In Stock |
| (3S,4S)-Tofacitinib | Impurity | CS-T-62104 | 1092578-47-6 | Enquire |
| 2,4-Dichloro-7H-Pyrrolo (2,3-d)Pyrimidine | Impurity | CS-M-42734 | 90213-66-4 | In Stock |
| 3H-pyrrolo[2,3-d]pyrimidin-4(5H)-one | Impurity | CS-O-55715 | 1194710-85-4 | Enquire |
| N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide | Impurity | CS-O-45589 | Not Available | Enquire |
| N-Desmethyl Tofacitinib | Impurity | CS-O-54946 | 1527525-58-1 | Enquire |
| N-methyl-N-(4-methylpiperidin-3-yl)nitrous amide | Impurity | CS-O-45599 | Not Available | Enquire |
| N-methyl-N-(4-methylpyridin-3-yl)nitrous amide | Impurity | CS-O-46286 | Not Available | Enquire |
| Tofacitinib formyl impurity | Impurity | CS-EO-01760 | 2227199-28-0 | In Stock |
| Tofacitinib Benzyl Impurity | Impurity | CS-T-88424 | 477600-73-0 | In Stock |
| Tofacitinib butyl ester impurity | Impurity | CS-O-43010 | Not Available | Enquire |
| Tofacitinib Butyl Impurity | Impurity | CS-O-54081 | 2716897-36-6 | Enquire |
| Tofacitinib Citrate Diasteromeric impurity | Impurity | CS-O-46779 | 2664002-63-3 | Enquire |
| Tofacitinib Diastereomer | Impurity | CS-EO-00128 | 344418-92-4 (Freebase) | Enquire |
| Tofacitinib Diastereomer-1 and 2 | Impurity | CS-O-33660 | 2734856-31-4 | Enquire |
| Tofacitinib Dihydro Citricacid salt impurity | Impurity | CS-O-44098 | 1809002-40-1 | Enquire |
| Tofacitinib Dihydro Impurity | Impurity | CS-T-89311 | 1640972-35-5 | In Stock |
| Tofacitinib Dimer | Impurity | CS-O-57969 | ---- | Enquire |
| Tofacitinib Hydroxy Impurity | Impurity | CS-EO-02225 | 1092578-46-5 | Enquire |
| Tofacitinib Impurity 19 | Impurity | CS-O-58215 | 2459302-82-8 | Enquire |
| Tofacitinib Impurity 29 | Impurity | CS-EO-03056 | 2459302-85-1 | Enquire |
| Tofacitinib Impurity 57 | Impurity | CS-EO-03055 | 2315287-12-6 | Enquire |
| Tofacitinib Impurity 59 | Impurity | CS-O-58346 | 32018-56-7 | Enquire |
| Tofacitinib Impurity 6 | Impurity | CS-EO-01450 | 2504210-38-0 | In Stock |
| Tofacitinib Impurity 67 | Impurity | CS-O-57488 | 2716897-35-5 | Enquire |
| Tofacitinib Impurity G | Impurity | CS-AQ-00037 | 1354486-07-9 | In Stock |
| Tofacitinib impurity K | Impurity | CS-AQ-00040 | 2328165-36-0 | In Stock |
| Tofacitinib Impurity L | Impurity | CS-AQ-00041 | 1675248-19-7 | In Stock |
| TOFACITINIB IMPURITY TOF-IV | Impurity | CS-O-49452 | 2227197-38-6 | Enquire |
| Tofacitinib impurity X | Impurity | CS-AQ-00050 | 2097982-05-1 | Enquire |
| Tofacitinib N-Descyanoacetyl Hydrochloride Impurity | Impurity | CS-O-10647 | 1260590-51-9 | In Stock |
| Tofacitinib N-Oxide Impurity | Impurity | CS-T-89823 | 2028267-73-2 | Enquire |
| (3S,4R) Tofacitinib Citrate | Impurity | CS-O-39728 | 2174011-54-0 | Enquire |
| 1-Piperidinepentanoic acid, γ-cyano-β-imino-4-methyl-3-(meth... | Impurity | CS-O-40534 | 2102039-99-4 | Enquire |
| 3-((3R,4R)-4-methyl-3-(methyl((5R,6S)-2,5,6-trihydroxy-6,7-d... | Impurity | CS-O-35885 | 2102039-98-3 | Enquire |
| 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-... | Impurity | CS-O-36711 | Not Available | Enquire |
| 5H,6H,7H-pyrrolo[2,3-d]pyrimidin-6-one | Impurity | CS-EM-02923 | 5817-96-9 | Enquire |
| Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R)) | Impurity | CS-EO-01834 | 2378663-15-9 | Enquire |
| Tofacitinib Impurity 16 | Impurity | CS-O-40535 | 2102040-00-4 | Enquire |
| Tofacitinib Impurity 36 | Impurity | CS-EO-01537 | Not Available | Enquire |
| Tofacitinib impurity C | Impurity | CS-AQ-00034 | Not Available | Enquire |
| Tofacitinib impurity F | Impurity | CS-AQ-00036 | Not Available | Enquire |
| Tofacitinib impurity I | Impurity | CS-AQ-00038 | Not Available | Enquire |
| Tofacitinib impurity J | Impurity | CS-AQ-00039 | 1431697-80-1 | Enquire |
| Tofacitinib impurity N | Impurity | CS-AQ-00042 | 1260614-73-0 | Enquire |
| Tofacitinib impurity P | Impurity | CS-AQ-00044 | 1252883-90-1 | Enquire |
| Tofacitinib impurity T | Impurity | CS-AQ-00046 | Not Available | Enquire |
| Tofacitinib impurity U | Impurity | CS-AQ-00047 | Not Available | Enquire |
| Tofacitinib impurity V | Impurity | CS-AQ-00048 | 1616761-00-2 | Enquire |
| Tofacitinib impurity W | Impurity | CS-AQ-00049 | Not Available | Enquire |
| Tofacitinib impurity Z | Impurity | CS-AQ-00052 | 477600-76-3 | Enquire |
| Tofacitinib- Keto Impurity | Impurity | CS-DN-00028 | Not Available | Enquire |
| Tofacitinib N- acid Impurity | Impurity | CS-DN-00027 | Not Available | Enquire |
| Tofacitinib N-hydroxy impurity | Impurity | CS-EO-00807 | Not Available | Enquire |
| Tofacitinib Related Compound 26 HCl | Impurity | CS-P-02224 | 1206824-85-2 | Enquire |
| Tofacitinib related compound 6 | Impurity | CS-P-02196 | 2459302-77-1 | Enquire |